𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Study of the Docetaxel–Carboplatin Chemotherapy Regimen in Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Nicolas Tsavaris; Christos Kosmas; Elias Skopelitis; Kostantinos Gennatas; Alexandra Zorbala; Paris Papas; Panagiotis Gouveris; George Antypas; Sofia Rokana; George Tzelepis

Publisher
Springer
Year
2005
Tongue
English
Weight
111 KB
Volume
183
Category
Article
ISSN
0341-2040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I-II study of docetaxel-ifosfami
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer
✍ Christos Kosmas; Nicolas B. Tsavaris; Thomas Makatsoris; Adimchi Onyenadum; Mari 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 1 views

## Abstract In an attempt to develop more effective chemotherapy regimens in advanced nonsmall cell lung cancer (NSCLC), we evaluated docetaxel‐ifosfamide‐cisplatin (DIP) based on our previous experience with paclitaxel‐ifosfamide‐cisplatin. Patients with advanced NSCLC (stages III‐IV), WHO‐PS≤2, n